Patents by Inventor Frank Norris

Frank Norris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10788350
    Abstract: In a submersible liquid level sensing system, a submersible transducer senses hydrostatic pressure of a liquid in which the transducer is submerged. In at least one embodiment, a pump controller controls the on/off operation of a pump in accordance with the sensed liquid level, based on an output of the transducer. The sensed liquid level is output by the transducer to the pump controller via a cable, which is covered by a ruggedized jacket configured to be slid over the cable and attached to the transducer. The jacket may be de-attached from the transducer with the jacketed cable operably connected to the transducer.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: September 29, 2020
    Assignee: LOFA Industries, LLC
    Inventor: Frank Norris
  • Publication number: 20190234788
    Abstract: In a submersible liquid level sensing system, a submersible transducer senses hydrostatic pressure of a liquid in which the transducer is submerged. In at least one embodiment, a pump controller controls the on/off operation of a pump in accordance with the sensed liquid level, based on an output of the transducer. The sensed liquid level is output by the transducer to the pump controller via a cable, which is covered by a ruggedized jacket configured to be slid over the cable and attached to the transducer. The jacket may be de-attached from the transducer with the jacketed cable operably connected to the transducer.
    Type: Application
    Filed: January 26, 2018
    Publication date: August 1, 2019
    Inventor: Frank Norris
  • Publication number: 20070292429
    Abstract: Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
    Type: Application
    Filed: April 4, 2007
    Publication date: December 20, 2007
    Inventors: James Brady, James Winchester, Vadim Davankov, Maria Tsyuruoa, Ludmila Pavlova, Frank Norris, Peter Quartararo, Jamie Salsberg
  • Publication number: 20070258983
    Abstract: Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
    Type: Application
    Filed: November 3, 2004
    Publication date: November 8, 2007
    Inventors: James Brady, James Winchester, Vadim Davankov, Maria Tsyurupa, Ludmila Pavlova, Frank Norris, Peter Quartararo, Jamie Salsberg
  • Publication number: 20070093739
    Abstract: Intravenous, or indwelling, or integratedmulti-functional devices and systems reduce levels of a targeted compound in blood by selective adsorption. The devices and systems can be used, e.g., to reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices and systems are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices and systems serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
    Type: Application
    Filed: December 5, 2006
    Publication date: April 26, 2007
    Inventors: James Brady, James Winchester, Vadim Davankov, Maria Tsyurupa, Ludmila Pavlova, Frank Norris, Peter Quartararo, Jamie Salsberg
  • Publication number: 20060057142
    Abstract: Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
    Type: Application
    Filed: October 19, 2005
    Publication date: March 16, 2006
    Inventors: James Brady, James Winchester, Vadim Davankov, Maria Tsyurupa, Ludmila Pavlova, Frank Norris, Peter Quartararo, Jamie Salsberg
  • Publication number: 20050239041
    Abstract: Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
    Type: Application
    Filed: April 13, 2005
    Publication date: October 27, 2005
    Inventors: James Brady, James Winchester, Vadim Davankov, Maria Tsyurupa, Ludmila Pavlova, Frank Norris, Peter Quartararo, Jamie Salsberg
  • Publication number: 20050061742
    Abstract: Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluid by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
    Type: Application
    Filed: November 4, 2004
    Publication date: March 24, 2005
    Inventors: James Brady, James Winchester, Vadim Davankov, Maria Tsyurupa, Ludmila Pavlova, Frank Norris, Peter Quartararo, Jamie Salsberg
  • Patent number: 4523104
    Abstract: A circuit for eliminating transient pulses generated by bouncing mechanical contacts within a switch. A shift register accepts a series of binary input signals from the switch and propagates the signal out the register in parallel to a logic device for generating a resultant binary signal corresponding to the switch's debounced signal state.
    Type: Grant
    Filed: February 22, 1983
    Date of Patent: June 11, 1985
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Frank A. Norris, David J. Krile